Subscribe to PRO at just Rs.33 per month. Use code SUPERPRO
Last Updated : Dec 02, 2016 10:42 AM IST | Source: CNBC-TV18

Stocks in news: Wipro, Coal India, Tata Motors, Clariant, BILT

L&T | Tata Power | Wipro | Coal India | Tata Motors | TVS Motor | Jindal Drilling | Shilpa Medicare | Clariant Chemicals | AstraZeneca | Reliance Communications | Crompton Greaves | Ballarpur Industries | JSPL | Bombay Dyeing and Advanced Enzymes are stocks, which are in the news today.

Here are stocks that are in news today:

Monthly auto sales: TVS Motor
-Total sales flat at 2.25 lakh units (YoY)
-Total 2-wheeler sales up 0.6 percent at 2.19 lakh units versus 2.17 units (YoY)
-Total 3-wheeler sales down 2.4 percent at 32,829 units versus 33,621 units (YoY)
Tata Motors
-Total sales flat at 38,900 units (YoY)
-Total exports up 57 percent at 5,626 units versus 3,573 units (YoY)
-Total domestic passenger vehicle sales up 22 percent at 12,736 units versus 10,470 units (YoY)
-Total domestic commercial vehicle sales down 17 percent at 20,538 units (YoY)
-Impact of demonetisation felt across all segments
-Long haul cargo operators severely affected by cash crunch
-JLR US sales up 18.9 percent at 9,040 units versus 7,604 units (YoY)
-Jaguar US sales up 217.5 percent at 3,381 units versus 1,065 units (YoY)
-Land Rover US sales down 13.5 percent at 5,659 units versus 6,539 units (YoY)
Hero Motocorp
-Total sales down 12.9 percent at 4.79 lakh units versus 5.5 lakh units (YoY)

Clariant Chemicals Q2
-Net profit up 40 percent at Rs 3.5 crore versus Rs 2.5 crore (YoY)
-Total income up 2.7 percent at Rs 255 crore versus Rs 248.3 crore (YoY)


USFDA approvals
-Aurobindo Pharma receives US FDA approval for Clozapine oral tablets
Alert: Clozapine is used to treat severe schizophrenia or to reduce the risk of suicidal behavior in people
-Novartis receives US FDA nod for Nateglinide oral tablets
ALERT: Nateglinide is used to control high blood sugar, especially in type 2 diabetes cases
-Alkem Labs receives tentative ANDA nod for Pregabalin oral capsules
-Lyrica is the market name of drug
Alert: Pregabalin is used to control seizures & to treat fibromyalgia
Alert: Pregabalin is used to treat pain caused by nerve damage in people with diabetes, herpes zoster or neuropathic pain associated with spinal cord injury
-Alkem Labs receives tentative approval for Lyrica generic from Daman facility: Sources
Alert: Daman unit received 13 US FDA observations post inspection in September
Alert: Daman facility contributes to around 30 percent of Alkem's US sales

Shilpa Medicare
-Board approves increase in FII limit to 40 percent from 30 percent
-Board approves issuing equity up to Rs 175 crore at Rs 570/share

Tata-DoCoMo case
-There is a prohibition on transactions sought by DoCoMo: RBI
-RBI files application in Delhi High Court
-Delhi HC agrees to hear RBI plea, issues notice to Tata, DoCoMo
-Next hearing on December 21
Tata Sons says
-Enforcement of award in favour of DoCoMo is against public policy
-Not just RBI, finance ministry has rejected transaction in question
-Want to make payment, have already deposited money in Delhi HC
-RBI rejected NOC to transaction at the behest of the finance ministry
-Cannot make payment to DoCoMo through overseas entities of Tata Sons
DoCoMo says
-Will be dampener for investors if FEMA comes in way of exit option for them
-Payments can be made through overseas entities of Tata Sons

RBI defines financing of infrastructure lending
-Large exposure framework will be effective from April 1, 2019
-Banks' exposure to a single company must not top 20 percent of eligible capital
-Exposure to a group must not top 25 percent of eligible capital

Naveen Jindal to CNBC-TV18
-Cement sales have gone down, expect hit on rebars due to demonetisation
-Till the time customers move to cashless payments, there will be a slowdown

Other stocks and sectors that are in news today:
-Aarti Drugs buyback window from December 2-16
-Binani Industries - CARE downgrades long term rating from B + to D
-Valecha Engineering seeks approval of shareholders/SEBI/Exchange for conversion of fixed deposits into equity
-IndusInd Bank proposal issue non-convertible debentures (NCDs) worth Rs 1,500 crore
-Coal India November coal production of 53.85 million tonne versus 50 million tonne (MoM); November offtake of 49.8 million tonne versus 48.16 million tonne (MoM)
-Jindal Drilling arbitration award of USD 31.76 million passed against the company
-AstraZeneca received notice to extend distribution arrangement for Meronem up to July 31, 2017
-United Bank of India revised interest rate on deposits above Rs 1 crore from 4.5-5 percent
-Jyothy Labs board meeting on December 8 to consider issue of NCDs
-KIC Metaliks resumed operations at plant after a major shutdown
-Wipro wins infra deal from Australian company – Woodside
-Shriram Transport Finance approved and allotted NCDs worth Rs 100 crore
-Reliance Communications plans USD 500 million offshore bond issue: ET
-Crompton Greaves, Ballarpur Industries: Aantha holdings set to win Rs 1,400 crore refinancing deal from KKR: ET
-Lenders invoke S4A, order audit of Jindal Steel & Power (JSPL): FE
-Government officials propse to break up Coal India into 7 within a year: FE
-Bombay Dyeing plans to treble retail turnover by 2020: BS
-L&T/Tata Power gets orders for 2 Pinkaka rocket units for Rs 3,230 crore: BS
-MCX says SEBI approves appointment of Saurabh Chandra as governing board chairman
-Advanced Enzymes board approves acquisition of JC Biotech for Rs 50 crore
-Ujjivan Financial Services submits application to RBI for registration as core investment company

First Published on Dec 2, 2016 08:01 am